Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
K. Ingrid Sprinz
Observed names:
Ingrid Sprinz,
Katherine Ingrid Sprinz
Observed institution:
Prothena (United States)
OpenAlex ID:
A5093399381
Pooled Analysis of Safety from Birtamimab Phase 1-3 Studies in Patients with Light Chain (AL) Amyloidosis
2023
·
Vaishali Sanchorawala
, Ashutosh D Wechalekar
, et al.
·
Blood
·
2
PDF
P-299 Health-Related Quality of Life in Patients With Mayo Stage IV Light Chain (AL) Amyloidosis Treated With Birtamimab Plus Standard of Care: Results From the VITAL Trial
2024
·
Anita D'Souza
, Vaishali Sanchorawala
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
P-101 Burden of AL Amyloidosis and its Association with Cardiac Involvement: Initial Results from a Patient-Reported Outcome Survey
2024
·
Kaitlin LaGasse
, Avery A. Rizio
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Health-Related Quality of Life (HRQoL) in Patients With Mayo Stage IV Light Chain (AL) Amyloidosis Treated With Birtamimab Plus Standard of Care (SoC): Results From the VITAL Trial PC43 (#346)
2024
·
Anita D'Souza
, Vaishali Sanchorawala
, et al.
Show more works
View as search
Works count:
4
Citation count:
2
H-index:
1
I10-index:
Year
Topic
Type
